Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP)

36 filings reported holding CAMP - Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share as of Q3 2025.
Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.2M shares of 46.6M outstanding shares and own 60.5% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (5.87M shares), JANUS HENDERSON GROUP PLC (4.64M shares), Vivo Capital, LLC (3.92M shares), ENAVATE SCIENCES GP, LLC (3.79M shares), FMR LLC (3.02M shares), a16z Capital Management, L.L.C. (2.13M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.96M shares), HarbourVest Partners LLC (1.27M shares), SILVERARC CAPITAL MANAGEMENT, LLC (654K shares), and VANGUARD GROUP INC (314K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.